Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232312 | SCV000289551 | likely benign | Brugada syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000601861 | SCV000716286 | likely benign | not specified | 2017-02-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002436035 | SCV002746188 | likely benign | Cardiovascular phenotype | 2019-06-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437026 | SCV004154210 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SCN10A: PM5, BS1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000601861 | SCV005202382 | likely benign | not specified | 2024-07-28 | criteria provided, single submitter | clinical testing |